Thermo Fisher to Acquire Affymetrix

The boards of both companies have agreed to a $1.3 billion deal, which is subject to Affymetrix shareholder approval.

By | January 11, 2016

WIKIMEDIA, NIAMSThermo Fisher Scientific said Friday (January 8) that it would acquire Affymetrix for $1.3 billion. According to MarketWatch, the boards of both companies have agreed to the deal, which must still be approved by Affymetrix shareholders.

“The acquisition of Affymetrix will strengthen our leadership in biosciences and create new market opportunities for us in genetic analysis,” Thermo Fisher President and CEO Marc Casper said in a statement (via 24/7 Wall Street). Frank Witney, president and CEO of Affymetrix, added: “We will be able to build on our strong history of close collaboration with customers in our target markets by leveraging Thermo Fisher’s deep relationships, particularly in biopharma.”.

(Hat tip: The Wall Street Journal)

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. That Other CRISPR Patent Dispute
    Daily News That Other CRISPR Patent Dispute

    The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.

  2. How Gaining and Losing Weight Affects the Body
    Daily News How Gaining and Losing Weight Affects the Body

    Millions of measurements from 23 people who consumed extra calories every day for a month reveal changes in proteins, metabolites, and gut microbiota that accompany shifts in body mass.

  3. Neurons Use Virus-Like Proteins to Transmit Information
  4. DOE-Sponsored Oak Ridge National Laboratory to Cut 100 More Jobs
AAAS